A BILL 
To allow for devices with a predetermined change control 
plan to be marketed without submitting a supplemental 
application or premarket notification if the changes to 
such devices are consistent with such plan. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. PREDETERMINED CHANGE CONTROL PLANS 
3
FOR DEVICES. 
4
(a) IN GENERAL.—Chapter V of the Federal Food, 
5
Drug, and Cosmetic Act (21 U.S.C. 351 et seq.) is amend-
6
ed by inserting after section 515B (21 U.S.C. 360e–3) the 
7
following: 
8
00:34 Jul 09, 2022
H8299
2 
•HR 8299 IH
‘‘SEC. 515C. PREDETERMINED CHANGE CONTROL PLANS 
1
FOR DEVICES. 
2
‘‘(a) APPROVED DEVICES.— 
3
‘‘(1) IN
GENERAL.—Notwithstanding section 
4
515(d)(5)(A), a supplemental application shall not 
5
be required for a change to a device approved under 
6
section 515, if such change is consistent with a pre-
7
determined change control plan that is approved 
8
pursuant to paragraph (2). 
9
‘‘(2) 
PREDETERMINED
CHANGE
CONTROL 
10
PLAN.—The Secretary may approve a predetermined 
11
change control plan submitted in an application, in-
12
cluding a supplemental application, under section 
13
515 that describes planned changes that may be 
14
made to the device (and that would otherwise re-
15
quire a supplemental application under section 515), 
16
if the device remains safe and effective without any 
17
change. 
18
‘‘(3) SCOPE.—The Secretary may require that a 
19
change control plan include labeling required for 
20
safe and effective use of the device as such device 
21
changes pursuant to such plan, notification require-
22
ments if the device does not function as intended 
23
pursuant to such plan, and performance require-
24
ments for changes made under the plan. 
25
‘‘(b) CLEARED DEVICES.— 
26
00:34 Jul 09, 2022
H8299
3 
•HR 8299 IH
‘‘(1) IN
GENERAL.—Notwithstanding section 
1
510(k), a premarket notification shall not be re-
2
quired for a change to a device cleared under section 
3
510(k), if such change is consistent with an estab-
4
lished predetermined change control plan granted 
5
pursuant to paragraph (2). 
6
‘‘(2) 
PREDETERMINED
CHANGE
CONTROL 
7
PLAN.—The Secretary may clear a predetermined 
8
change control plan submitted in a notification sub-
9
mitted under section 510(k) that describes planned 
10
changes that may be made to the device (and that 
11
would otherwise require a new notification), if— 
12
‘‘(A) the device remains safe and effective 
13
without any such change; and 
14
‘‘(B) the device would remain substantially 
15
equivalent to the predicate. 
16
‘‘(3) SCOPE.—The Secretary may require that a 
17
change control plan include labeling required for 
18
safe and effective use of the device as such device 
19
changes pursuant to such plan, notification require-
20
ments if the device does not function as intended 
21
pursuant to such plan, and performance require-
22
ments for changes made under the plan. 
23
‘‘(c) PREDICATE DEVICES.—In making a determina-
24
tion of substantial equivalence pursuant to section 513(i), 
25
00:34 Jul 09, 2022
H8299
4 
•HR 8299 IH
the Secretary shall not compare a device to changed 
1
versions of a device implemented in accordance with an 
2
established predetermined change control plan as a predi-
3
cate device. Only the version of the device cleared or ap-
4
proved, prior to changes made under the predetermined 
5
change control plan, may be used by a sponsor as a predi-
6
cate device.’’. 
7
(b) CONFORMING AMENDMENTS.— 
8
(1) CLEARED
DEVICES.—Section 510(l)(1) of 
9
the Federal Food, Drug, and Cosmetic Act (21 
10
U.S.C. 360(l)(1)) is amended, in the first sentence, 
11
by inserting ‘‘, or with respect to a change that is 
12
consistent with a predetermined change control plan 
13
cleared under section 515C’’ before the period at the 
14
end. 
15
(2) 
APPROVED
DEVICES.—Section 
16
515(d)(5)(A)(i) of the Federal Food, Drug, and Cos-
17
metic Act (21 U.S.C. 360e(d)(5)(A)(i)) is amended 
18
by striking ‘‘A supplemental’’ and inserting ‘‘Unless 
19
the change is consistent with a predetermined 
20
change control plan approved under section 515C, a 
21
supplemental’’. 
22
(3) DOCUMENTATION OF RATIONALE FOR SIG-
23
NIFICANT
DECISIONS.—Section 517A(a)(1) of the 
24
00:34 Jul 09, 2022
H8299
5 
•HR 8299 IH
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
1
360g–1(a)(1)) is amended to read as follows: 
2
‘‘(1) IN GENERAL.—The Secretary shall provide 
3
a substantive summary of the scientific and regu-
4
latory rationale for any significant decision of the 
5
Center for Devices and Radiological Health regard-
6
ing submission or review of a report under section 
7
510(k), a petition for classification under section 
8
513(f), an application under section 515, or an ap-
9
plication for an exemption under section 520(g), in-
10
cluding documentation of significant controversies or 
11
differences of opinion and the resolution of such con-
12
troversies or differences of opinion.’’. 
13
Æ 
00:34 Jul 09, 2022
H8299
